One Meal A Day — OMAD — represents the far end of the time-restricted eating spectrum. Where standard 16:8 intermittent fasting involves a 16-hour daily fast, OMAD condenses all daily caloric intake into a single meal consumed within a 1–2 hour window, implying a 22–23 hour daily fast. It has attracted a devoted following who report dramatic simplicity benefits, significant fat loss, and sustained energy once adaptation occurs.
As with most extreme dietary interventions, the reality is more nuanced than advocates suggest. OMAD produces genuine metabolic effects that standard intermittent fasting does not — but it also introduces specific risks around muscle maintenance, hormonal balance, and nutritional adequacy that require careful management.
What Happens Physiologically During a 22–23 Hour Fast
Extending the fasting window from 16 to 22–23 hours amplifies several metabolic processes beyond what standard intermittent fasting achieves:
Deeper autophagy: Autophagy — the cellular self-cleaning process — accelerates significantly with fast duration. While detectable autophagy begins at approximately 12–16 hours, research suggests that 20–24 hour fasts produce substantially more robust autophagic activity, with greater cellular protein aggregate clearance and organelle recycling. This is the physiological basis for OMAD's purported anti-aging and cellular renewal benefits.
Greater growth hormone elevation: Growth hormone rises progressively throughout a fast, reaching peak elevations at 24 hours that are dramatically higher than those at 16 hours. A 1988 New England Journal of Medicine study documented 1,300–2,000% increases in growth hormone secretion during 24-hour fasts — an endocrine environment that theoretically protects lean mass during the fasting period.
More extensive ketosis: While some people enter mild ketosis after 16 hours, most adults reliably enter meaningful ketosis in the 20–24 hour range when hepatic glycogen is sufficiently depleted. This ketotic state provides an alternative brain fuel, reduces appetite through ketone-mediated ghrelin suppression, and shifts fatty acid oxidation to rates not achievable in shorter fasting windows.
More complete insulin suppression: Extended insulin suppression through a longer fasting period maximizes insulin sensitivity restoration and the fat-mobilizing environment that insulin normally blocks.
The Weight Loss Evidence
OMad's weight loss mechanism is essentially caloric: most people consuming a single meal cannot realistically consume as many calories as they would spread across 3–5 meals — even when attempting to eat their full daily caloric requirement. Gastric capacity limits single-meal size, appetite hormones are substantially suppressed after extended fasting in ways that limit meal size, and the psychological challenge of consuming 1,500–2,000 calories in one sitting is considerable.
Studies directly examining OMAD versus standard caloric restriction have found comparable weight loss outcomes when total caloric intake is matched — consistent with the conclusion that OMAD's weight loss advantage stems primarily from its calorie-restricting effect rather than any unique metabolic mechanism independent of caloric intake.
A 2022 study published in the New England Journal of Medicine directly compared OMAD (unrestricted eating during a 1-hour window) to standard caloric restriction over one year in people with obesity and type 2 diabetes. Both groups lost comparable amounts of weight and showed similar improvements in metabolic markers — suggesting that the metabolic benefits of OMAD are largely achievable with equivalent caloric reduction through conventional dietary restriction, though OMAD participants reported finding the approach simpler to sustain.
The Critical Challenges: Why OMAD Fails for Many People
Protein Adequacy and Muscle Mass
The most significant nutritional challenge of OMAD is consuming adequate protein in a single meal. As established throughout this series, optimal muscle protein synthesis requires 30–40g of high-quality complete protein per meal, with distribution across multiple meals being important for maximizing daily muscle protein balance.
Consuming 120–150g of total daily protein in a single meal is physiologically possible but practically demanding — and the research on protein distribution suggests that even when daily totals are met, single-meal protein intake is less effective at maintaining muscle protein synthesis rates than the same protein distributed across 3–4 meals. A 2020 study confirmed that even at adequate daily protein totals, OMAD-style protein distribution produced lower whole-day muscle protein synthesis rates than distribution across multiple meals.
For people using OMAD for fat loss specifically, this muscle protein synthesis limitation means that without deliberate resistance training and maximum-possible protein intake at the single meal, lean mass losses will be disproportionate to fat losses — worsening body composition rather than improving it.
Nutrient Completeness
Consuming a micronutrient-complete diet in a single meal is extraordinarily challenging. The diversity of vitamins, minerals, and phytonutrients required for optimal function is difficult to deliver when the volume of food that can be consumed at one sitting is physically limited. OMAD practitioners commonly develop insufficiencies in micronutrients spread across multiple food groups — particularly if food choices at the single meal are limited by appetite saturation before all nutritional categories are covered.
Hormonal Effects in Women
Significant evidence suggests that extended daily fasting, particularly in the 20–24 hour range, disrupts hypothalamic-pituitary-ovarian axis function in women more readily than in men. The hypothalamus is exquisitely sensitive to energy availability signals — fasting that drops energy availability below a threshold triggers hypothalamic suppression of LH and FSH pulsatility, potentially causing menstrual irregularity, reduced fertility, and estrogen decline in susceptible women.
Women interested in the benefits of extended fasting would generally be better served by 14–18 hour fasting windows rather than the full OMAD protocol — capturing significant metabolic benefits with meaningfully lower hypothalamic disruption risk.
Social and Behavioral Sustainability
OMad structurally eliminates participation in breakfast and lunch social eating — a significant quality of life reduction for many people that translates into long-term adherence failure. The research on dietary intervention sustainability consistently finds that social compatibility is one of the strongest predictors of long-term maintenance, and OMAD's incompatibility with social meal sharing limits its realistic application.
Who May Benefit From OMAD
OMad has the most rational application for:
- Metabolically healthy adults with confirmed excellent body composition who primarily seek simplicity and are willing to accept modest lean mass trade-offs for weight management ease
- People who genuinely struggle with hunger management and find that eliminating the first two meals eliminates their snacking and overconsumption patterns more effectively than moderate restriction
- Short-term fat loss phases (4–6 weeks) before returning to standard eating patterns
- People who have naturally low appetite and find themselves gravitating toward de facto OMAD eating without deliberate restriction
OMad is specifically contraindicated for: people with history of eating disorders, athletes with significant performance demands, pregnant and breastfeeding women, people with type 1 or insulin-dependent type 2 diabetes, adolescents, and older adults with sarcopenia risk.
A Safer Alternative: 18:6 or 20:4 Time-Restricted Eating
For people attracted to OMAD's extended fasting benefits but concerned about the muscle, nutrient, and hormonal risks, an 18:6 window (6-hour eating, 18-hour fast) or 20:4 window captures most of OMAD's metabolic advantages while allowing 2–3 appropriately-timed meals that address protein distribution, micronutrient completeness, and social eating compatibility.
The Bottom Line
OMad produces genuine metabolic effects through its extended fasting window — deeper autophagy, greater ketosis, sustained growth hormone elevation, and appetite reduction through a structural limitation on eating opportunities. But its muscle maintenance challenges, micronutrient adequacy difficulties, hormonal disruption risks in women, and social incompatibility make it a high-complexity intervention appropriate for specific individuals rather than a broadly recommendable eating pattern. For most people seeking extended fasting benefits, 16:8 to 18:6 time-restricted eating captures the majority of documented benefits with substantially fewer risks.
